InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-07 | 2026-04-07 | Higuchi John W. | Director | Purchase | 40.0K | $2.03 | $81K | 203.8K | View ↗ | |
| 2026-04-06 | 2026-04-06 | Higuchi John W. | Director | Purchase | 123.0K | $2.05 | $252K | 163.8K | View ↗ | |
| 2026-04-06 | 2026-04-06 | Patel Mahesh V. | Director & Chief Executive Officer | Purchase | 25.0K | $2.03 | $51K | 160.7K | View ↗ | |
| 2026-04-02 | 2026-04-02 | Patel Mahesh V. | Director & Chief Executive Officer | Purchase | 25.0K | $2.02 | $51K | 135.7K | View ↗ |
No annual data found.
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression